68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
Trial ID or NCT#
NCT03809078
Status
NOT RECRUITING
Purpose
The objective of the study is to evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in patients with suspected prostate cancer.
Official Title
A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Suspected prostate cancer - Planned prostate biopsy - Able to provide written consent - Karnofsky performance status of 50 (or ECOG/WHO equivalent)
Exclusion Criteria:
- - Patients not capable of getting PET study due to weight, claustrophobia, or inability to lay still for the duration of the exam - Metallic implants (contraindicated for MRI)
Investigator(s)
Geoffrey Sonn
Urologic oncologist,
Urologist,
Urologic specialist,
Genitourinary specialist,
Urologic surgeon
Associate Professor of Urology and, by courtesy, of Radiology (Body MRI)
Pejman Ghanouni, MD, PhD
Radiologist
Associate Professor of Radiology (General Radiology) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology
Contact us to find out if this trial is right for you.
Contact
Brittney Williams
650-736-3688
View on ClinicalTrials.gov
